The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine

Neuropharmacology

Volumn 54, Issue 3, 2008, Pages 564-568

  Marquez, Paul ^a   Nguyen, Alexander T ^a   Hamid, Abdul ^a   Lutfy, Kabirullah ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Acute reward; Cocaine; Conditioned place preference; Knockout mouse; ORL 1 receptor; Orphanin FQ nociceptin

Indexed keywords

COCAINE; J 13397; NOCICEPTIN; OPIATE ANTAGONIST; OPIATE RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; DRUG EFFECT; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; WILD TYPE;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; BENZIMIDAZOLES; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIPERIDINES; RECEPTORS, OPIOID; REWARD; TIME FACTORS;

EID: 38649142826     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.11.003     Document Type: Article

References (27)

1. Bardo M.T., and Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl.) 153 (2000) 31-43
2. Ciccocioppo R., Angeletti S., Sanna P.P., Weiss F., and Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur. J. Pharmacol. 404 (2000) 153-159
3. Devine D.P., Taylor L., Reinscheid R.K., Monsma Jr. F.J., Civelli O., and Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21 (1996) 1387-1396
4. Di Giannuario A., Pieretti S., Catalani A., and Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Neurosci. Lett. 272 (1999) 183-186
5. Kawamoto H., Ozaki S., Itoh Y., Miyaji M., Arai S., Nakashima H., et al. Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397). J. Med. Chem. 42 (1999) 5061-5063
6. Koizumi M., Sakoori K., Midorikawa N., and Murphy N.P. The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism. Br. J. Pharmacol. 143 (2004) 53-62
7. Kotlinska J., Wichmann J., Legowska A., Rolka K., and Silberring J. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Behav. Pharmacol. 13 (2002) 229-235
8. Kotlinska J., Rafalski P., Biala G., Dylag T., Rolka K., and Silberring J. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur. J. Pharmacol. 474 (2003) 233-239
9. Lutfy K., Do T., and Maidment N.T. Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl.) 154 (2001) 1-7
10. Lutfy K., Khaliq I., Carroll F.I., and Maidment N.T. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl.) 164 (2002) 168-176
11. Lutfy K., Eitan S., Bryant C.D., Yang Y.C., Saliminejad N., Walwyn W., et al. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J. Neurosci. 23 (2003) 10331-10337
12. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., and Leslie F.M. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. Neuroreport 13 (2002) 1137-1140
13. Marquez P., Baliram R., Gajawada N., Friedman T.C., and Lutfy K. Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine. Behav Neurosci 120 (2006) 10-15
14. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
15. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53 (2001) 381-415
16. Murphy N.P., and Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem. 73 (1999) 179-186
17. Murphy N.P., Lee Y., and Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832 (1999) 168-170
18. Narayanan S., Lam H., Maidment N.T., and Lutfy K. Cocaine Sensitization Increases the Level of Orphanin FQ-immunoreactivity in the Rat Hypothalamus (2000), 31st INRC, Washington, USA Abs
19. Narayanan S., Lam H., Carroll F.I., and Lutfy K. Orphanin FQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats. J. Psychiatry Neurosci. 29 (2004) 116-123
20. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
21. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
22. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J. 16 (1997) 1858-1864
23. Norton C.S., Neal C.R., Kumar S., Akil H., and Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J. Comp. Neurol. 444 (2002) 358-368
24. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270 (1995) 792-794
25. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma Jr. F.J., and Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273 (1998) 1490-1495
26. Sakoori K., and Murphy N.P. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berl.) 172 (2004) 129-136
27. Zheng F., Grandy D.K., and Johnson S.W. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro. Br. J. Pharmacol. 136 (2002) 1065-1071